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We previously reported 3,4-di-O-caﬀeoylquinic acid (CQC) protected vascular endothelial cells against oxidative stress and
restored impaired endothelium-dependent vasodilatation. Here, we further investigated its anti-atherosclerotic eﬀect against
angiotensin II (Ang II) evoked proliferation and migration of cultured rat vascular smooth muscle cells (rVSMC). The results
showedCQC(1–20μM) clearlyinhibited Ang-II-stimulated BrdU incorporationandcell migrationofrVSMCin a concentration-
dependent manner but without signiﬁcantcytotoxicity. Western blot analysis revealed Ang II increased the phosphorylation levels
of Akt and mitogen-activated protein kinases (MAPKs;p38, ERK1/2 and JNK) in rVSMC. In the presence of phosphatidylinositol
3-kinase (PI3K) inhibitor wortmannin and three individual MAPK inhibitors SB203580, PD98059 and SP600125, both Ang-II-
induced cell proliferation and migration were signiﬁcantly attenuated, although to diﬀering extents, suggesting the PI3K and
MAPK signal pathways all participated in regulating rVSMC proliferation and migration. Also, the CQC pretreatment markedly
suppressed Ang-II-induced phosphorylationof Aktand JNK rather than ERK1/2, although it failed to aﬀect p38 phosphorylation.
In conclusion, our data demonstrate CQC may act by down-regulating Akt, JNK and part of the ERK1/2 pathways to inhibit
Ang-II-induced rVSMC proliferation and migration. The anti-atherosclerotic eﬀect of CQC is achieved either by endothelial
cells protection or by VSMC proliferation/migration inhibition, suggesting this compound may be useful in preventing vascular
diseases.
1.Introduction
Migration and proliferation of vascular smooth muscle cells
(VSMCs) are critical events in the development of restenosis
and in theprogression ofatherosclerosis[1].A growing body
of evidence supports the ﬁnding that angiotensin II (Ang II)
plays an important role in the pathogenesis of several car-
diovascular diseases associated with VSMC proliferation
and migration. Ang II also promotes the generation of ox-
idative stress in the vasculature, appearing to be a key medi-
ator of Ang-II-induced VSMC proliferation and migra-
tion, endothelial cell apoptosis and endothelial dysfunction,
lipoproteinperoxidationandadhesionmoleculesexpression,
all of which participate in the induction of atherosclerosis.
Diﬀerent signal transduction cascades have been impli-
cated in Ang-II-mediated cell growth and migration, such
as the mitogen-activated protein kinase (MAPK) pathways
[2]. Furthermore, reactive oxygen species (ROS) generation
in response to Ang II stimuli has been shown to relate to the
activation of MAPKs and induces proliferation of VSMCs
[3]. On the other hand, Ang II has been shown to acti-
vate phosphatidylinositol 3-kinases (PI3Ks) in the cultured
porcine carotid artery VSMC [4]. PI3K play a major role in
a wide range of cellular processes, including motility and
cell cycle progression [5]. Recent evidence suggests the PI3K
pathway is implicated in VSMC mitogenesis. Shigematsu
et al. [6] showed activating PI3K is essential for initiating
medial VSMC replication after balloon injury in rats. In
addition, the direct role of PI3K in Ang-II-induced DNA
synthesis and proliferation has been described in cultured
porcine carotid artery VSMC [4]. One of the major down-
s t r e a mt a r g e t so fP I 3 Ki sA k t .T h er e s u l t so b t a i n e df r o m
Dugourd et al. [7] provide the ﬁrst evidence of a speciﬁc and
necessary role of Akt in Ang-II-induced proliferation.2 Evidence-Based Complementary and Alternative Medicine
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Figure 1: Various anti-oxidative properties by CQC. In cell free
system, CQC displayed potent antioxidant activity to inhibit Cu2+-
induced oxidation of human LDL (a) and scavenge DPPH free
radical (b).In cultured HUVECs, CQCminimized notonlythe loss
ofcell viabilityinducedbyoxidativestressbutalsotheROS-induced
impairment of endothelium-dependent relaxation to acetylcholine
in rat aorta (c).
Antioxidants such as resveratrol possess many biologic
activities including protection from or reduction of the
incidence of coronary heart disease [8] and a direct relaxant
eﬀect on the vascular smooth muscle [9]. Chao et al. also
reported resveratrol caninhibitAng-II-inducedproliferation
in rat aortic smooth muscle cells [10]. We previously
demonstrated 3,4-di-O-caﬀeoylquinic acid (CQC), a phe-
nolic constituent isolated from a Taiwanese folk medicine
Elephantopus mollis, minimized not only the loss of cell
viability induced by oxidative stress in cultured human
umbilical veinendothelial cells(HUVECs) butalso the ROS-
induced impairment of endothelium-dependent relaxation
to acetylcholine in rat aorta through an antioxidant property
(Figure 1(c))[ 11]. However, whether CQC helps prevent
VSMCs from atherosclerotic damage remains unclear. In the
present study, we investigate the eﬀect of CQC on Ang-II-
induced migration and proliferation of rat cultured VSMC
and further delineated the possibly involved action mecha-
nisms.
2.Methods
2.1. Materials. 3,4-Di-O-caﬀeoylquinic acid (CQC) was iso-
lated by our own laboratory [11]. Its purity determined by
high-performance liquidchromatographywithanultraviolet
detector was between 99.1 and 99.8%. This drug was ﬁrst
dissolved in dimethylsulphoxide at 100 mM and then serially
diluted in PBS immediately prior to experiments. Stock
solution of CQC was used within 1 week after preparation.
For examination of the eﬀect of CQC, 10 μl of drug solution
was added to 1 ml culture medium. Ang II, SB203580, PD
98059 and SP600125 were obtained from Sigma-Aldrich
(St. Louis, MO, USA). Wortmannin was procured from
Calbiochem (Merck Ltd, Taiwan). Alamar Blue Assay kit
and BrdU cell proliferation assay kit was purchased from
Serotec (Oxford, UK) and Chemicon (Millipore, MA, USA),
respectively. Dulbecco’s modiﬁed Eagle’s medium (DMEM)
was purchased from GIBCO/BRL (Grand Island, NY 14072,
USA). Fetal bovine serum (FBS), penicillin, streptomycin
and trypsin/EDTA were obtained from Biological Industries
(Kibbutz Beit Haemek 25115, Israel). VSMC-speciﬁc goat
anti-actin and HRP anti-rabbit antibody were purchased
from Santa Cruz (Santa Cruz, CA, USA). Antibodies against
total (i.e., inactivated) and the phosphorylated (i.e., acti-
vated) forms of p38, ERK1/2, JNK and Akt were purchased
from Cell Signaling Technology (Beverly, MA, USA). ECL
reagent was obtained from Amersham Pharmacia (Bucking-
hamshire, UK).
2.2. Culture of Rat Vascular Smooth Muscle Cells (rVSMC).
The investigation was approved by the IACUC of National
Research Institute of Chinese Medicine. VSMC were isolated
from the thoracic aorta of 6- to 8-week-old male Sprague-
Dawley rats by explant culture. Subcultures were prepared
by dissociation of cells with trypsin/EDTA (Sigma-Aldrich)
and seeding into appropriate culture dishes and grown until
approximately 80% conﬂuent in DMEM containing 10%
FBS, 100 μg/ml penicillin and 100 U/ml streptomycin (com-
plete medium) under standardized culture condition. Cells
were identiﬁed as VSMC by their characteristic morphology
as well as with antibodies to VSMC-speciﬁc goat anti-actin
and were used from passage 3 to 10. VSMCs were grown
in complete medium until 12h prior to experimentation,
at which time cells were incubated in low serum medium
(0.3% FCS) for all experiments. Cells were then pre-
incubated with diﬀerent concentrations of CQC for 30min
and then stimulated with or without Ang II for diﬀerent
incubationtimesasindicated,followed byproliferationassay
or harvesting for western blot analysis. Cellular viability was
determined by Alamar Blue assay.
2.3. Cell Viability Measurement. Cellviability was monitored
by Alamar Blue Assay kit as described previously [12]. After
incubation with or without CQC, Alamar Blue growth
indicator dye (10%, v/v) was added to cell culture for
another 4h incubation at 37◦C. The change in colour
could be monitored with an ELISA reader at 620nm. Wells
containing medium and Alamar Blue dye without cells wereEvidence-Based Complementary and Alternative Medicine 3
used as blanks. All experiments were performed in duplicate
and repeated at least twice with similar results. The mean
absorbance for the duplicate cultures of each drug was cal-
culated and the mean blank value was subtracted from these.
Cell viability in control medium without any treatment was
represented as 100%.
2.4. Cell Proliferation Analysis. rVSMCs proliferation was
measured by using the BrdU cell proliferation assay kit
according to the manufacturer’s protocol. In brief, rVSMCs
w e r eg r o w ni nl o ws e r u mm e d i u m( 0 . 3 %F C S )f o r1 2ht o
induce cell growth arrest. After the quiescent cells were pre-
treated with or without diﬀerent concentrations of tested
drugs (CQC or protein kinase inhibitors) for 30min, Ang II
were added to the medium and incubated for further 48h.
After that, BrdU was added and the cells were reincubated
f o r4h .A f t e rr e m o v i n gt h ec u l t u r em e d i u m ,r V S M C sw e r e
ﬁxed and the DNA denatured. Then, peroxidase-labelled
anti-BrdUwas addedtobindtotheBrdU.The immunecom-
plexes were detected by the 3,3 ,5,5 -tetramethyl-benzidine
substratereaction, andtheresultantcolorwasread at450nm
in a microplate spectrophotometer. The absorbance values
correlated directly to the amount of DNA synthesis and
thereby to the number of proliferating cells in culture.
2.5. Migration Assay. Cell migration was assessed using a 24-
well Transwell with a membrane pore size of 5μm( C o r n i n g
Costar, NY, USA) as previously described [12]. Brieﬂy, 90μl
of rVSMC (1.0 × 106 ml−1) were added to each of the
upper wells in the presence of 10μl PBS or drugs (CQC
or protein kinase inhibitors) for 30min, respectively. The
lower well was ﬁlled with 600μl of serum-free medium that
contained 100nM Ang II to assess the migration activity.
After incubation for 8h at 37◦Ci na5 %C O 2 incubator,
ﬁlters were cut and the cells on the top surface of the
membrane were removed with a cotton swab. The cells
that had migrated to the lower side of the ﬁlter were ﬁxed,
stained with Haematoxylin solution and counted under
a microscope (magniﬁcation, ×400) for quantiﬁcation of
rVSMC migration [13]. Migration activity was calculated
as the mean number of migrated cells observed in four
high-power ﬁelds and given as the mean value of four
measurements. In the experiment that presence of protein
kinase inhibitors, Ang-II- induced migration was designated
as 100% and results were represented as relative migration.
2.6.Cell Extracts Preparation and Western BlotAnalysis. After
incubation, cell pellets were lysed with ice-cold lysis buﬀer
and centrifuged at 45000g for 1h at 4◦C to yield the whole
cell extract in the supernatants [12]. Protein concentration
was determined using BCA reagents (Pierce, USA) according
to the manufacturer’s manual. Protein (40μg) was separated
using 8% SDS-polyacrylamide gel and transferred to a
nitrocellulose membrane. After blocking,the membrane was
incubated(overnightat4◦C)withantibodiesthatspeciﬁcally
detect the total and the phosphorylated forms of p38,
ERK1/2, JNK and Akt, respectively. Then, it was incubated
with HRP anti-rabbit antibody and detected by ECL. The
results were evaluated by densitometry analysis.
2.7. Statistics. All values in the text and ﬁgures represent
mean ± SE. Statistical signiﬁcance was determined using a
two-tailedStudentt-test.StatisticalsigniﬁcancewithPvalues
of <.01 or <.001 were designated with a single “∗”o rd o u b l e
“∗∗”, respectively.
3.Results
3.1. CQ Inhibited Ang-II-Induced Proliferation of rVSMC.
The results shown in Figure 2(a) indicated growth-arrested
rVSMCs treated with Ang II (1–1000nM) signiﬁcantly
increased BrdU incorporation in a concentration-dependent
manner. Compared to the control group, 100nM of Ang II
treatment increased cellular proliferation by about 200%. In
the presence of CQC (1, 5, 10 and 20μM), 100nM Ang-
II-stimulated cell proliferation was signiﬁcantly inhibited
in a concentration-dependent manner (Figure 2(b)). Cell
viability assay indicated none of the concentrations used for
CQC displayed signiﬁcant cytotoxicity: cell viability in the
presence of 20μM CQC in rVSMCs was greater than 92 ±
5%.
3.2. Ang-II-Induced Migration of rVSMC Was Suppressed by
CQC. The stimulatory eﬀect of Ang II on the migration
of rVSMC is shown in Figure 3(a).A se x p e c t e d ,A n gI I
(1–1000nM) induced cell migration in a concentration-
dependent manner. The increase in migration activity was
maximal at the concentration of 100nM Ang II. In the
presence of CQC, such migration was signiﬁcantly and dose-
dependently inhibited (Figure 3(b)).
3.3. Protein Kinases Phosohorylation in Response to Ang II
Stimulation. It haspreviously beenreported Ang-II-induced
signalling in VSMC involves the activation of multiple pro-
tein kinases. Thus, we measured Ang-II-induced kinase
phosphorylation in rVSMCs. When cells were stimulated
withAngII,thephosphorylationofthethreeMAPKswereall
signiﬁcantly induced as early as 10min after the stimulation
and lasted up to 60min, and diminishing after that (data
not shown). Thus, the 10 min incubation period was chosen
to assess the concentration-dependent eﬀect of Ang II.
Figure 4(a) shows the phosphorylation of p38, ERK1/2 and
JNK in rVSMCs was increased after being stimulated with
Ang II (1–100nM) for 10 min, reaching a maximal response
at 100nM Ang II (n = 4). Western blots probed for Akt
(a downstream target for PI3K) phosphorylation at the
Serine 473 site were analyzed as a measure of Akt activation.
The phosphorylation of Akt also showed concentration-
dependent increases and was consistent with MAPK phos-
phorylation stimulated by Ang II.
3.4. Ang-II-Induced Proliferation and Migration of rVSMCs
Were Suppressed by MAPK and PI3K Inhibitors. To clar-
ify whether the Ang-II-induced proliferation or migration4 Evidence-Based Complementary and Alternative Medicine
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Figure 2: rVSMC proliferation. (a) Concentration-dependent re-
sponsiveness of Ang-II-induced rVSMC proliferation. (b) 3,4-di-
O-caﬀeoylquinic acid dose-dependently inhibited 100 nM Ang-II-
induced proliferation.
∗P<. 01 and
∗∗P<. 001, signiﬁcant diﬀer-
ence versus samples treated with Ang II alone. Each histogram
represents the mean ± SE of three separate experiments run in
triplicate on four separate cultures.
is really mediated by the MAPK or PI3K signal path-
ways, rVSMCs were pretreated with p38 MAPK inhibitor
SB203580 (10μM), MEK1/2 inhibitor PD98059 (10μM),
JNK inhibitor SP600125 (10μM) or PI3K inhibitor wort-
mannin (100nM) for 30 min then stimulated with 100nM
Ang II for subsequent migration or proliferation assay,
respectively. Figures 4(b) and 4(c) show stimulation with
AngIIcauseda217±12anda327±19%signiﬁcantincrease
in the proliferation and migration of rVSMC, respectively,
compared to the control levels (= 100%). Ang-II-induced
proliferation of rVSMC was signiﬁcantly suppressed by all
protein kinase inhibitors treatment. The results showed
SB203580, PD98059 and wortmannin almost eliminated
the Ang II eﬀect on proliferation. SP600125 also signiﬁ-
cantly inhibited such proliferation, although to a lesser ex-
tent than inhibition by the others. In the case of migration,
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Figure 3: rVSMC migration. (a) Concentration-dependent re-
sponse of Ang-II-induced rVSMC migration. (b) 3,4-di-O-caffe-
oylquinic acid dose-dependently inhibited 100nM Ang-II-induced
migration.
∗P<. 01 and
∗∗P<. 001, signiﬁcant diﬀerence versus
samples treated with Ang II alone. Each histogram represents the
mean ± SE of three separate experiments run in triplicate on four
separate cultures.
pretreatment with SB203580 and wortmannin abrogated
the Ang II eﬀect. SP600125 also modestly reduced Ang-II-
induced migration; however, PD98059 failed to aﬀect such a
response (Figure 3(c)). These results indicated p38, ERK1/2,
J N Ka sw e l la sP I 3 Ka c t i v a t i o nm a ya l lb ee s s e n t i a lf o rA n g -
II-stimulated proliferation in VSMCs. Nevertheless, p38 and
PI3K rather than JNK and ERK1/2 were shown to play more
important rolesinmediating Ang-II-stimulatedmigrationin
rVSMCs.
3.5.CQC Signiﬁcantly AttenuatedERK1/2,JNKand AktPhos-
phorylationInduced byAngII. TodemonstratewhetherCQC
inhibited Ang-II-induced rVSMC proliferation or migration
by aﬀecting the activation of MAPK signals, we analyzed the
phosphorylation levels of p38, ERK1/2 and JNK in responseEvidence-Based Complementary and Alternative Medicine 5
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Figure 4: Ang-II induced protein kinses phosphorylation, prolifer-
ation and migration. (a) Concentration-dependent responsiveness
of Ang-II-induced phosphorylation of p38, ERK1/2, JNK and Akt.
(b) Eﬀects of SB203580, PD98059, SP600125 and wortmannin on
the Ang-II-induced rVSMC proliferation. (c) Eﬀects of SB203580,
PD98059, SP600125 and wortmannin on the Ang-II-induced
rVSMC migration.
∗P<. 01 and
∗∗P<. 001, signiﬁcant diﬀerence
versussamplestreated withAngIIalone.Eachhistogramrepresents
the mean ± SE of three separate experiments run in triplicate on
three separate cultures.
to Ang II after CQC treatment. The results showed Ang-II-
stimulated increases of ERK1/2 and JNK phosphorylation
were inhibited by this drug in a concentration-dependent
manner, respectively (Figure 5(a)). Signiﬁcant reduction of
JNK phosphorylation began at 5μMC Q Cp r e t r e a t m e n t ,
while ERK1/2 phosphorylation was signiﬁcantly attenuated
i nt h ep r e s e n c eo f1 0μM CQC. In contrast, Ang-II-evoked
phosphorylation of p38 MAPK was not reduced by CQC
treatment. On the other hand, CQC at a concentration of
5μM clearly, and at a concentration of 10μM completely,
suppressed the eﬀect of Ang II on Akt phosphorylation
(Figure 5(b)). These results indicated the eﬀects of CQC on
Ang-II-induced proliferation/migration in rVSMCs may be
mediated by a coordinated inhibition of the ERK1/2, JNK
and Akt signalling pathways.
4.Discussion
A n gI Ia c t i n gt h r o u g ht h eA T 1r e c e p t o rt om e d i a t eV S M C
proliferation and migration are important events in the for-
mation of the neointima in pathological states such as athe-
rosclerosis and hypertension [14]. Thus, inhibition ofVSMC
proliferation ormigration represents a potentially important
therapeutic strategy for treating such diseases. In this paper,
our data demonstrated CQC signiﬁcantly inhibited not
only Ang-II-induced proliferation but also cell migration of
rVSMC in a concentration-dependent manner. These results
indicated CQCmay be a potential pharmaceutical to prevent
atherosclerosis.
Manyofthesignalling eventsrelevanttocellproliferation
are mediated through activation of transcription factors by
MAPKs, which can be upregulated by Ang II [2, 15]. Our
resultssupporttheaboveidea,sinceAngIIreallyupregulated
the phosphorylation of p38, ERK1/2 and JNK in rVSMCs
(Figure 4(a))andAng-II-inducedcellproliferationwasabro-
gated in the presence of three individual MAPK inhibitors
(Figure 4(b)). We also found CQC signiﬁcantly inactivated
JNKphosphorylation onAng-II-stimulatedrVSMCatacon-
centrationof5μM, butitseﬀecton ERK1/2phosphorylation
was observed at a relatively high concentration of 10 μM.
In contrast, Ang-II-induced phosphorylation of p38 was
not nearly as aﬀected by this compound. Therefore, the
antiproliferative property of CQC on rVSMC was associated
with the downregulation of JNK rather than the ERK1/2
pathway.
PI3Ks also play a major role in a wide range of cellular
processes, including motility and cell cycle progression [5].
Recent evidence suggests the PI3K pathway is implicated
in VSMC proliferation. Shigematsu et al. showed activating
PI3K is essential for initiating medial VSMC replication
after balloon injury in rats [6]. In addition, a direct role
of PI3K in Ang II-induced DNA synthesis and proliferation
has been described in cultured porcine carotid artery VSMC
[4]. One of the major downstream targets of PI3K is
serine/threonine kinase Akt (also known as protein kinase
B). Once phosphorylated, Akt activates various proteins
involved in many cellular responses, including cell survival
and growth promotion [16]. It has recently been shown6 Evidence-Based Complementary and Alternative Medicine
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Figure 5: Eﬀects of 3,4-di-O-caﬀeoylquinic acid on the Ang-II-induced phosphorylation of p38, ERK1/2, JNK and Akt, respectively.
Representative results of the western blots are shown in the top panels, and the data in the bottom panels represent the mean ± SE of
four separate experiments.
∗P<. 01 and
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the main biological end points preceding cell proliferation and
migration in response to Ang II. ROS activate hypertrophy and
proliferation in VSMC. In response to the growth factors Ang
II or PDGF, ROS are endogenously produced by VSMC and
stimulate MAPKs and Akt. Our data documented that CQC
inhibited Ang-II-induced rVSMC proliferation and migration. The
anti-atherosclerotic property of CQC may act by downregulating
the Akt, JNK and in part of ERK1/2 pathways by Ang II. AT1:
angiotensin type 1 receptor; GFR: growth factor receptor; Gq: Gq
protein.
Akt is phosphorylated and activated by the AT1 receptor in
a PI3K-dependent manner in various cell types including
VSMC [17, 18]. Dugourd et al. provided a direct role of Akt
in Ang II-mediated cell proliferation in rat aortic SMC and
suggested Akt stimulation by the AT1 receptor takes place
downstream of PI3K activation [7]. We also reconﬁrmed the
important role of Akt in the Ang-II-induced proliferation
of rVSMC based on the observations Ang-II-evoked a
signiﬁcant phosphorylation of Akt and Ang-II-induced cell
proliferation was wortmannin sensitive. The present results
demonstrated CQC clearly blocked Ang-II-activated phos-
phorylation of Akt suggesting interruption of the PI3K/Akt
signal pathway also participated in antiproliferative activity
by CQC.
Cell migration is mediated by intracellular kinases in-
cluding Src, focal adhesion kinase and PI3K, and MAPK is a
downstream target of all these kinases [19]. Afterperforming
the functional assay using individual kinases inhibitors, our
results indicated the p38 and PI3K signal pathways, but not
ERK1/2 pathway, were heavily involved in Ang-II-induced
migration of rVSMC (Figure 4(c)). Phosphorylation of JNK
also played a role in mediating rVSMC migration, however,
to a lesser extent. The results obtained here concluded CQC
displayed antimigration activity either by inactivating the
MAPK signal pathway, particularly JNK, or by downregula-
tion of the PI3K/Akt pathway stimulated by Ang II.
Mounting evidence suggests Ang II activates the NADPH
oxidase system and promotes the generation of ROS in vitro,
ex vivo and in vivo [20]. Viedt et al. [21]r e p o r t e dt h er a d i c a l
species scavenger N-acetyl cysteine or the inhibitor of
NADPH oxidase antagonizes the stimulatory eﬀects of Ang
II on MAPK activity. These suggested ROS acts as a scaﬀold
molecule linking the signal network between Ang II and
MAPKs. In fact, we previously found CQC displayed antiox-
idant activity more potent than resveratrol in chelating
the 1,1-diphenyl-2-picrylhydrazyl (DPPH) free radical and
inhibiting Cu2+-induced oxidation of human low-density
lipoprotein (LDL; Figures 1(a) and 1(b))[ 11]. Furthermore,
this compound not only eﬀectivelyminimized the loss of cell
viabilityinducedbyFenton’sreagentinculturedHUVECbut
also signiﬁcantly reversed H2O2/FeSO4-induced impairment
of endothelium-dependent relaxation to acetylcholine in rat
aorta (Figure 1(c)). These data suggested CQC prevents cells
from undergoing oxidative stress and its scavenging of free
radicals could be the key mechanism contributing to the
cytoprotective eﬀect of CQC.
Several biological activities, such as the neuroprotective
[22, 23], analgesic [24] and antioxidant [25, 26]p r o p e r t i e s
havebeenreported forcaﬀeoylquinicacid orCQC.However,
this is the ﬁrst paper demonstrating CQC can inhibit Ang-
II-induced rVSMC proliferation and migration, probably
through downregulating the Akt, JNK and part of the
ERK1/2 pathways, in which the anti-oxidant property plays
an important role. The proposed molecular targets of CQC
to inhibit Ang-II-induced proliferation and/or migration of
VSMC are summarized in Figure 6.H u n ge ta l .[ 27]e x a m -
ined theantioxidantactivity of six caﬀeoylquinicacidderiva-
tives (including CQC) from the roots of Dipsacus asper Wall.
They reported these compounds were potent scavengers of
DPPH and had the ability to inhibit LDL oxidation as well
as the thiobarbituric acid reactive substances formation.
Based on these ﬁnding, Hung et al. suggested caﬀeoylquinic
acid derivatives may have a role to play in preventing the
development and progression of atherosclerotic disease. In
conclusion, the present study provided some support for
the idea that CQC may oﬀer a therapeutic strategy for
the pathogenesis of Ang-II-related vascular diseases such
as hypertension or atherosclerosis. It may also serve as a
promising cardiovascular antiproliferative or antimigratory
agent. Whether CQC acts onmore upstream signal pathways
beyond protein kinase or ROS requires further study.
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